Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

dual-drug PLA-TPGS nanoparticles

Based on

1 Articles
2014 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

poly(lactide)-D-α-tocopheryl polyethylene glycol 1000 succinate

PLA-TPGS
Type Polymer
Formula
Role raw materials
2

docetaxel/tamoxifen mixture

DCL/TAM mixture
Type Complex Compound
Formula
Role loaded material

Properties

General physical and chemical properties

Property Value Source

Full content is available to subscribers only

To view content please choose from the following:

Applications

Area Application Source

Full content is available to subscribers only

To view content please choose from the following:

Characterization

Method Source

Full content is available to subscribers only

To view content please choose from the following:

Biological effects

Biological system Test details Source

Full content is available to subscribers only

To view content please choose from the following:

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • poly(lactide)-D-α-tocopheryl polyethylene glycol 1000 succinate
  • 1,7β,10β-trihydroxy-9-oxo-5β,20-epoxytax-11-ene-2α,4,13α-triyl 4-acetate 2-benzoate 13-{(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoate}
  • 2-{4-[(1Z)-1,2-diphenylpent-1-en-1-yl]phenoxy}ethyl)dimethylamine
  1. laggrqmY7IOaE0UPZVwEz
Product

dual-drug PLA-TPGS nanoparticles

Method 2

Type: Physical formation
Source:
Starting materials
  • poly(lactide)-D-α-tocopheryl polyethylene glycol 1000 succinate
  • 1,7β,10β-trihydroxy-9-oxo-5β,20-epoxytax-11-ene-2α,4,13α-triyl 4-acetate 2-benzoate 13-{(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoate}
  • 2-{4-[(1Z)-1,2-diphenylpent-1-en-1-yl]phenoxy}ethyl)dimethylamine
  1. aFfjs0d5FmvnjneswUmQB
Product

dual-drug PLA-TPGS nanoparticles

Method 3

Type: Physical formation
Source:
Starting materials
  • poly(lactide)-D-α-tocopheryl polyethylene glycol 1000 succinate
  • 1,7β,10β-trihydroxy-9-oxo-5β,20-epoxytax-11-ene-2α,4,13α-triyl 4-acetate 2-benzoate 13-{(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoate}
  • 2-{4-[(1Z)-1,2-diphenylpent-1-en-1-yl]phenoxy}ethyl)dimethylamine
  1. U2pPPSfe3MAmCb82JnSwp
Product

dual-drug PLA-TPGS nanoparticles

Method 4

Type: Physical formation
Source:
Starting materials
  • 1,7β,10β-trihydroxy-9-oxo-5β,20-epoxytax-11-ene-2α,4,13α-triyl 4-acetate 2-benzoate 13-{(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoate}
  • poly(lactide)-D-α-tocopheryl polyethylene glycol 1000 succinate
  • 2-{4-[(1Z)-1,2-diphenylpent-1-en-1-yl]phenoxy}ethyl)dimethylamine
  1. AuUQ1cZ93vBGo1SgLcy6f
Product

dual-drug PLA-TPGS nanoparticles

Method 5

Type: Physical formation
Source:
Starting materials
  • poly(lactide)-D-α-tocopheryl polyethylene glycol 1000 succinate
  • 1,7β,10β-trihydroxy-9-oxo-5β,20-epoxytax-11-ene-2α,4,13α-triyl 4-acetate 2-benzoate 13-{(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoate}
  • 2-{4-[(1Z)-1,2-diphenylpent-1-en-1-yl]phenoxy}ethyl)dimethylamine
  1. 9xow6jemAE6SeTEneIZ21
Product

dual-drug PLA-TPGS nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial